Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

LITSLite Strategy, Inc.

Nasdaq · CIK 0001262104
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC6199 Finance Services
FY end0630
XBRL facts341

Identity from submissions API

NameLite Strategy, Inc.
CIK0001262104
TickersLITS
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC6199 Finance Services
EIN510407811
LEI—
Fiscal year end0630
State of incorporationDE DE
Phone858-369-7100
Website—
Investor website—
Owner org09 Crypto Assets
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • MEI Pharma, Inc. (2012-07-02T04:00:00.000Z → 2025-09-10T04:00:00.000Z)
  • MARSHALL EDWARDS INC (2003-09-25T04:00:00.000Z → 2012-06-06T04:00:00.000Z)
Business address
9920 PACIFIC HEIGHTS BLVD
SUITE 150
SAN DIEGO
CA
92121
CA
Mailing address
9920 PACIFIC HEIGHTS BLVD
SUITE 150
SAN DIEGO
CA
92121
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1027 filing rows loaded from submissions recent; extra archives: CIK0001262104-submissions-001.json (27 filings, 2003-09-25 to 2004-11-10).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 4 4 0001193125-26-468824 26566
2026-11-18 4 4 0001193125-26-467053 5173
2026-11-05 10-Q 10-Q 0001193125-26-449764 001-41827 261527165 34 11611972 1 1
2026-11-03 8-K 8-K 3.02 0001193125-26-445292 001-41827 261517161 34 150539 1 1
2026-10-26 4 4 0001193125-26-432220 8713
2026-10-26 4 4 0001193125-26-432167 5786
2026-10-26 4 4 0001193125-26-432165 5906
2026-10-26 4 4 0001193125-26-432164 5877
2026-10-26 4 4 0001193125-26-432162 5917
2026-10-06 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-003162 333-299169 261445362 33 1950
2026-09-28 S-8 S-8 0001193125-26-405431 333-299172 261417895 33 326353 1 1
2026-09-28 S-3 S-3 0001193125-26-405423 333-299169 261417802 33 839462 1 1
2026-09-28 10-K 10-K 0001193125-26-405328 001-41827 261417334 34 15351856 1 1
2026-08-03 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001079973-26-000999 005-79594 261233141 34 6897
2026-07-30 8-K 8-K 2.02,9.01 0001193125-26-325026 001-41827 261220349 34 176864 1 1
2026-07-24 8-K 8-K 7.01 0001193125-26-316284 001-41827 261202425 34 6193183 1 1
2026-06-25 4 4 0001193125-26-282864 5187
2026-05-13 8-K 8-K 2.02,9.01 0001193125-26-220697 001-41827 26971097 34 260863 1 1
2026-05-13 10-Q 10-Q 0001193125-26-220687 001-41827 26971057 34 11265389 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-016538 005-79594 26642999 34 18483
2026-02-17 8-K 8-K 2.02,9.01 0001193125-26-053243 001-41827 26636811 34 261197 1 1
2026-02-17 10-Q 10-Q 0001193125-26-053215 001-41827 26636775 34 10732597 1 1
2026-02-12 4 4 0001193125-26-049089 5982
2026-02-12 8-K 8-K 5.02,5.07,9.01 0001193125-26-049005 001-41827 26627544 34 369412 1 1
2026-01-27 DEFA14A defa14a.htm 0000929638-26-000268 001-41827 26565423 34 12835
2025-12-30 ARS ARS 0001193125-25-337093 001-41827 251614366 34 1647686
2025-12-30 DEFA14A DEFA14A 0001193125-25-337076 001-41827 251614252 34 863101
2025-12-30 DEF 14A DEF 14A 0001193125-25-337041 001-41827 251614159 34 7021620 1 1
2025-12-30 8-K 8-K 5.02,9.01 0001193125-25-335761 001-41827 251610984 34 377027 1 1
2025-12-22 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001079973-25-001892 005-79594 251592713 34 6834
2025-12-22 4 xslF345X05/ownership.xml 0001079973-25-001891 5549
2025-12-22 4 4 0001193125-25-328666 5049
2025-12-05 8-K 8-K 4.01,9.01 0001193125-25-309593 001-41827 251552835 34 162469 1 1
2025-11-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003383 333-290779 251523698 33 1950
2025-11-21 CORRESP filename1.htm 0001193125-25-291318 12683
2025-11-20 4/A 4/A 0001193125-25-290061 5998
2025-11-20 8-K/A 8-K/A 5.02 0001193125-25-290059 001-41827 251504027 34 155559 1 1
2025-11-20 4 4 0001193125-25-289712 5048
2025-11-19 4 4 0001193125-25-287655 5782
2025-11-18 4 4 0001193125-25-286568 5757
2025-11-18 4 4 0001193125-25-286429 8246
2025-11-18 4 4 0001193125-25-286427 5728
2025-11-18 4 4 0001193125-25-286426 5614
2025-11-18 8-K 8-K 5.02 0001193125-25-286424 001-41827 251495756 34 150918 1 1
2025-11-14 10-Q 10-Q 0001193125-25-283111 001-41827 251487148 34 7818550 1 1
2025-10-31 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000102909-25-000273 005-79594 251438847 34 6404
2025-10-30 8-K 8-K 5.02,8.01,9.01 0001193125-25-258474 001-41827 251435328 34 173032 1 1
2025-10-08 S-3 S-3 0001193125-25-234596 333-290779 251382892 33 658535
2025-10-06 4 4 0001193125-25-231823 5455
2025-10-02 4 4 0001193125-25-228265 5047
2025-09-26 10-K 10-K 0001193125-25-220421 001-41827 251350352 34 14355507 1 1
2025-09-15 8-K 8-K 3.02 0001193125-25-203520 001-41827 251314287 34 151662 1 1
2025-09-10 3 xslF345X02/ownership.xml 0001079973-25-001446 4092
2025-09-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001079973-25-001444 005-79594 251306308 34 8030
2025-09-10 8-K 8-K 5.03,7.01,9.01 0001262104-25-000009 001-41827 251304775 34 198944 1 1
2025-09-05 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002851 333-289312 251298405 33 1851
2025-09-05 424B3 424B3 0001140361-25-034209 333-289312 251297175 33 595483
2025-09-04 8-K mei8k.htm 1.01,2.03,9.01 0000929638-25-003398 001-41827 251293860 34 326061 1 1
2025-09-03 CORRESP filename1.htm 0000929638-25-003343 5444
2025-08-26 S-3/A S-3/A 0001140361-25-032760 333-289312 251258737 33 642875
2025-08-20 4 xslF345X05/form4.xml 0000929638-25-003120 5219
2025-08-20 3 xslF345X02/form3.xml 0000929638-25-003118 8761
2025-08-20 UPLOAD filename1.pdf 0000000000-25-008865 333-289312 48075
2025-08-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001079973-25-001248 005-79594 251208160 34 6716
2025-08-06 S-3 S-3 0001140361-25-029159 333-289312 251190315 33 1204247 1 1
2025-08-06 8-K 8-K 5.02 0000950170-25-103990 001-41827 251189475 34 148755 1 1
2025-08-05 8-K 8-K 7.01,8.01,9.01 0000950170-25-102419 001-41827 251182889 34 177074 1 1
2025-07-30 8-K 8-K 3.02 0000950170-25-100341 001-41827 251167734 34 148882 1 1
2025-07-30 3 xslF345X02/form3.xml 0000929638-25-002826 9592
2025-07-29 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-071808 005-79594 251163095 34 28064
2025-07-28 144 xsl144X01/primary_doc.xml 0000921895-25-002032 001-41827 251157066 33 5108
2025-07-24 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000921895-25-002023 005-79594 251146798 34 99197
2025-07-23 144 xsl144X01/primary_doc.xml 0000921895-25-002020 001-41827 251144140 33 4997
2025-07-23 424B5 424B5 0001140361-25-026950 333-277201 251143512 33 339096
2025-07-22 8-K 8-K 1.01,1.02,3.02,5.02,8.01,9.01 0001140361-25-026773 001-41827 251141094 34 1965428 1 1
2025-07-17 4 xslF345X05/form4.xml 0000929638-25-002639 6955
2025-07-17 4 xslF345X05/form4.xml 0000929638-25-002638 5741
2025-07-17 4 xslF345X05/form4.xml 0000929638-25-002637 5174
2025-07-17 4 xslF345X05/form4.xml 0000929638-25-002636 5718
2025-07-17 4 xslF345X05/form4.xml 0000929638-25-002635 5224
2025-07-17 4 xslF345X05/form4.xml 0000929638-25-002634 5651
2025-05-13 8-K 8-K 2.02,9.01 0000950170-25-070298 001-41827 25939939 34 581672 1 1
2025-05-13 10-Q 10-Q 0000950170-25-070276 001-41827 25939774 34 6550978 1 1
2025-03-07 8-K 8-K 5.02,9.01 0000950170-25-035544 001-41827 25720530 34 282519 1 1
2025-02-12 8-K 8-K 2.02,9.01 0000950170-25-018820 001-41827 25614754 34 575783 1 1
2025-02-12 10-Q 10-Q 0000950170-25-018809 001-41827 25614662 34 6731009 1 1
2025-01-31 8-K 8-K 5.07 0000950170-25-011790 001-41827 25578741 34 172984 1 1
2024-12-20 ARS ARS 0000950170-24-139142 001-41827 241568985 34 2532539
2024-12-20 DEFA14A DEFA14A 0000950170-24-139138 001-41827 241568922 34 356810
2024-12-20 DEF 14A DEF 14A 0000950170-24-139131 001-41827 241568865 34 3561987 1 1
2024-11-25 8-K 8-K 5.08 0000950170-24-130593 001-41827 241496319 34 153846 1 1
2024-11-14 8-K 8-K 2.02,9.01 0000950170-24-127054 001-41827 241462187 34 395386 1 1
2024-11-12 10-Q 10-Q 0000950170-24-125328 001-41827 241447959 34 6260435 1 1
2024-10-25 8-K 8-K 1.01,2.01,9.01 0000950170-24-117406 001-41827 241397076 34 731541 1 1
2024-09-19 10-K 10-K 0000950170-24-108185 001-41827 241311234 34 9685554 1 1
2024-09-19 8-K 8-K 2.02 0000950170-24-108171 001-41827 241311135 34 407745 1 1
2024-08-02 8-K 8-K 5.02,9.01 0000950170-24-089939 001-41827 241170912 34 161875 1 1
2024-07-30 8-K 8-K 7.01,9.01 0000950170-24-087841 001-41827 241157329 34 27724296 1 1
2024-07-22 8-K 8-K 2.05,5.02,7.01,9.01 0000950170-24-085347 001-41827 241132353 34 178811 1 1
2024-07-22 144 xsl144X01/primary_doc.xml 0001957799-24-000158 001-41827 241131566 33 5935
2024-06-25 8-K mei8k.htm 8.01 0000929638-24-002259 001-41827 241068934 34 154917 1 1
2024-05-21 4 4 0000950170-24-062850 6165
2024-05-21 8-K 8-K 7.01,9.01 0000950170-24-062739 001-41827 24968128 34 19417063 1 1
2024-05-20 4 4 0000950170-24-062362 4927
2024-05-09 8-K 8-K 2.02,9.01 0000950170-24-056850 001-41827 24930322 34 471765 1 1
2024-05-09 10-Q 10-Q 0000950170-24-056834 001-41827 24930270 34 7760751 1 1
2024-02-28 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-02-28 14:00:00 9999999995-24-000572 333-277201 24698578 33 1847
2024-02-28 424B5 424B5 0000950170-24-022047 333-277201 24695176 33 326358
2024-02-26 CORRESP filename1.htm 0000950170-24-019942 22988
2024-02-23 UPLOAD filename1.pdf 0000000000-24-002066 333-277201 40425
2024-02-21 8-K 8-K 8.01,9.01 0000950170-24-017875 001-41827 24659258 34 499704 1 1
2024-02-20 S-3 S-3 0000950170-24-017279 333-277201 24655167 33 627687
2024-02-14 SC 13G/A AMENDMENT NO. 1 0001214659-24-002874 005-79594 24637368 34 89199
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-021449 005-79594 24628945 34 13111
2024-02-13 8-K 8-K 2.02,9.01 0000950170-24-014643 001-41827 24628457 34 443317 1 1
2024-02-13 10-Q 10-Q 0000950170-24-014640 001-41827 24627554 34 6997269 1 1
2024-01-17 8-K 8-K 5.02 0000950170-24-005013 001-41827 24538362 34 151241 1 1
2024-01-12 4/A 4/A 0000950170-24-004228 8140
2024-01-12 4/A 4/A 0000950170-24-004226 8178
2023-12-26 8-K 8-K 4.01,9.01 0000950170-23-073079 001-41827 231513887 34 163764 1 1
2023-12-22 8-K 8-K 5.03,9.01 0000950170-23-072612 001-41827 231509678 34 291322 1 1
2023-12-20 4 4 0000950170-23-072036 7877
2023-12-20 4 4 0000950170-23-072035 7840
2023-12-18 8-K 8-K 5.07 0000950170-23-071066 001-41827 231493634 34 176059 1 1
2023-12-11 8-K 8-K 8.01,9.01 0000950170-23-069381 001-41827 231478086 34 809537 1 1
2023-11-14 3 xslF345X02/form3.xml 0000929638-23-003139 9545
2023-11-09 8-K 8-K 2.02,9.01 0000950170-23-062017 001-41827 231392331 34 486064 1 1
2023-11-09 10-Q 10-Q 0000950170-23-061976 001-41827 231392113 34 7135035 1 1
2023-11-08 ARS ARS 0000950170-23-061251 001-41827 231389114 34 17455611
2023-11-08 DEFA14A DEFA14A 0000950170-23-061248 001-41827 231389093 34 67134
2023-11-08 DEF 14A DEF 14A 0000950170-23-061245 001-41827 231389077 34 4800600 1 1
2023-11-06 3 OWNERSHIP DOCUMENT 0000921895-23-002471 2963
2023-11-03 3 xslF345X02/form3.xml 0000929638-23-003001 8213
2023-11-01 SC 13D/A AMENDMENT NO. 8 TO THE SCHEDULE 13D 0000921895-23-002439 005-79594 231369239 34 433700
2023-11-01 DFAN14A dfan14a13392004_11012023.htm 0000921895-23-002438 001-41827 231369191 34 31722
2023-11-01 DEFA14A DEFA14A 0001193125-23-268297 001-41827 231368996 34 27188
2023-11-01 8-K 8-K 1.01,5.02,7.01,9.01 0001193125-23-268167 001-41827 231368103 34 373383 1 1
2023-10-27 10-K/A 10-K/A 0000950170-23-055978 001-41827 231355527 34 3854091 1 1
2023-10-24 4 OWNERSHIP DOCUMENT 0000921895-23-002375 13459
2023-10-24 4 OWNERSHIP DOCUMENT 0000921895-23-002374 23699
2023-10-24 SC 13D/A AMENDMENT NO. 7 TO THE SCHEDULE 13D 0000921895-23-002371 005-79594 231343307 34 434358
2023-10-18 DEFA14A DEFA14A 0001193125-23-257811 001-41827 231330495 34 30074
2023-10-17 DEFC14A DEFC14A 0001193125-23-257772 001-41827 231330439 34 292233
2023-10-13 4 OWNERSHIP DOCUMENT 0000921895-23-002340 11159
2023-10-13 4 OWNERSHIP DOCUMENT 0000921895-23-002339 21406
2023-10-13 SC 13D/A AMENDMENT NO. 6 TO THE SCHEDULE 13D 0000921895-23-002338 005-79594 231325592 34 434574
2023-10-12 4 xslF345X05/form4.xml 0000929638-23-002774 5929
2023-10-12 4 xslF345X05/form4.xml 0000929638-23-002773 5077
2023-10-12 4 xslF345X05/form4.xml 0000929638-23-002772 5222
2023-10-12 4 xslF345X05/form4.xml 0000929638-23-002771 5174
2023-10-12 4 xslF345X05/form4.xml 0000929638-23-002770 5065
2023-10-12 4 xslF345X05/form4.xml 0000929638-23-002769 5168
2023-10-12 4 xslF345X05/form4.xml 0000929638-23-002768 5149
2023-10-12 4 xslF345X05/form4.xml 0000929638-23-002767 5128
2023-10-12 CORRESP filename1.htm 0001193125-23-255099 14421
2023-10-12 PRER14A PRER14A 0001193125-23-255096 001-41827 231323436 34 279387
2023-10-10 DFAN14A dfan14a13392004_10102023.htm 0000921895-23-002328 001-41827 231317666 34 40535
2023-10-10 DEFC14A defc14a13392004_10102023.htm 0000921895-23-002326 001-41827 231316421 34 319189
2023-10-03 8-A12B 8-A12B 0001193125-23-249443 001-41827 231301529 34 40990
2023-10-03 8-K 8-K 1.01,3.03,5.03,7.01,9.01 0001193125-23-249423 000-50484 231301506 34 551624 1 1
2023-10-02 DEFA14A DEFA14A 0001193125-23-249212 000-50484 231300816 34 24376
2023-09-29 PREC14A prec14a13392004_09292023.htm 0000921895-23-002271 000-50484 231298028 34 296327
2023-09-29 DFAN14A dfan14a13392004_09292023.htm 0000921895-23-002270 000-50484 231296612 34 15753
2023-09-28 DEFA14A DEFA14A 0001193125-23-245801 000-50484 231290888 34 25294
2023-09-28 CORRESP filename1.htm 0001193125-23-245636 27596
2023-09-28 PRER14A PRER14A 0001193125-23-245634 000-50484 231289698 34 263836
2023-09-26 DFAN14A dfan14a13392004_09262023.htm 0000921895-23-002256 000-50484 231281309 34 38199
2023-09-26 SC 13D/A AMENDMENT NO. 5 TO THE SCHEDULE 13D 0000921895-23-002255 005-79594 231281287 34 436279
2023-09-26 8-K 8-K 2.02,9.01 0001193125-23-242526 000-50484 231280828 34 248608 1 1
2023-09-26 10-K 10-K 0000950170-23-049927 000-50484 231280586 34 9483391 1 1
2023-09-26 DEFC14A defc14a13392004_09262023.htm 0000921895-23-002248 000-50484 231280352 34 316306
2023-09-25 4 OWNERSHIP DOCUMENT 0000921895-23-002232 17310
2023-09-25 4 OWNERSHIP DOCUMENT 0000921895-23-002231 11171
2023-09-25 UPLOAD filename1.pdf 0000000000-23-010521 51906
2023-09-22 4 xslF345X05/e618957_4-anson.xml 0001193805-23-001317 16660
2023-09-22 4 xslF345X05/e618956_4-meipharm.xml 0001193805-23-001316 10436
2023-09-22 DFAN14A dfan14a13392004_09222023.htm 0000921895-23-002214 000-50484 231272523 34 19221
2023-09-22 SC 13D/A AMENDMENT NO. 4 TO THE SCHEDULE 13D 0000921895-23-002213 005-79594 231272504 34 434370
2023-09-22 PX14A6G LETTER TO MEIP SHAREHOLDERS 0001769022-23-000007 000-50484 34 9686
2023-09-18 DEFA14A DEFA14A 0001193125-23-236927 000-50484 231261383 34 21726
2023-09-18 CORRESP filename1.htm 0001193125-23-236643 24524
2023-09-15 PREC14A PREC14A 0001193125-23-236265 000-50484 231260280 34 254336
2023-09-15 SC 13D/A AMENDMENT NO. 3 TO THE SCHEDULE 13D 0000921895-23-002182 005-79594 231259621 34 489473
2023-08-08 SC 13D/A AMENDMENT NO. 2 TO THE SCHEDULE 13D 0000921895-23-001840 005-79594 231152111 34 254557
2023-08-04 PRRN14A e618825_prrn14a-meip.htm 0001193805-23-001099 000-50484 231144921 34 267687
2023-08-01 3 xslF345X02/form3.xml 0000929638-23-002140 4238
2023-07-27 8-K 8-K 5.02,9.01 0001193125-23-196279 000-50484 231119503 34 205885 1 1
2023-07-24 8-K 8-K 1.02,5.07,8.01,9.01 0001193125-23-191945 000-50484 231103887 34 187520 1 1
2023-07-19 DFAN14A dfan14a13392004_07192023.htm 0000921895-23-001699 000-50484 231097108 34 22570
2023-07-19 425 425 0001193125-23-189612 000-50484 231096718 34 125940
2023-07-19 8-K 8-K 1.02,8.01,9.01 0001193125-23-189610 000-50484 231096701 34 279251 1 1
2023-07-18 425 425 0001193125-23-188940 000-50484 231095094 34 77126
2023-07-18 8-K 8-K 8.01,9.01 0001193125-23-188930 000-50484 231095059 34 221659 1 1
2023-07-17 DFAN14A dfan14a13392004_07172023.htm 0000921895-23-001682 000-50484 231091993 34 22459
2023-07-17 SC 13D/A AMENDMENT NO. 1 TO THE SCHEDULE 13D 0000921895-23-001681 005-79594 231091992 34 268918
2023-07-17 425 425 0001193125-23-188095 000-50484 231091671 34 55916
2023-07-17 8-K 8-K 8.01,9.01 0001193125-23-188090 000-50484 231091658 34 196721 1 1
2023-07-17 PREC14A prec14a13392004_07142023.htm 0001193805-23-000990 000-50484 231090685 34 240969
2023-07-13 424B3 424B3 0001193125-23-186573 333-271481 231086977 33 18599
2023-07-13 425 425 0001193125-23-186572 000-50484 231086954 34 55665
2023-07-13 8-K 8-K 8.01,9.01 0001193125-23-186570 000-50484 231086930 34 196178 1 1
2023-07-10 PX14A6G LETTER TO MEIP SHAREHOLDERS 0001769022-23-000004 000-50484 34 10263
2023-07-07 425 425 0001193125-23-183855 000-50484 231077454 34 54958
2023-07-07 8-K 8-K 8.01,9.01 0001193125-23-183853 000-50484 231077443 34 195578 1 1
2023-07-05 425 425 0001193125-23-182035 000-50484 231070438 34 1026188
2023-07-05 8-K 8-K 8.01,9.01 0001193125-23-182031 000-50484 231070407 34 1169295 1 1
2023-07-03 424B3 424B3 0001193125-23-181391 333-271481 231065765 33 342279
2023-06-29 425 425 0001193125-23-178585 000-50484 231057446 34 59791
2023-06-29 8-K 8-K 8.01,9.01 0001193125-23-178569 000-50484 231057330 34 201546 1 1
2023-06-28 425 425 0001193125-23-176635 000-50484 231049121 34 59584
2023-06-28 8-K 8-K 8.01,9.01 0001193125-23-176628 000-50484 231049114 34 199892 1 1
2023-06-20 425 425 0001193125-23-169511 000-50484 231023264 34 8926715
2023-06-20 8-K 8-K 7.01,9.01 0001193125-23-169500 000-50484 231023246 34 9097710 1 1
2023-06-14 S-8 S-8 0001193125-23-166271 333-272627 231012832 33 61519
2023-06-13 425 425 0001193125-23-166032 000-50484 231011332 34 357068
2023-06-13 8-K 8-K 5.02,9.01 0001193125-23-166013 000-50484 231011248 34 570378 1 1
2023-06-06 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2023-06-06 16:00:00 9999999995-23-001644 333-271481 23997570 33 1798
2023-06-06 4 xslF345X04/form4.xml 0000929638-23-001688 5180
2023-06-06 424B3 424B3 0001193125-23-161633 333-271481 23996336 33 6308327
2023-06-05 CORRESP filename1.htm 0001193125-23-160720 5854
2023-06-05 S-4/A S-4/A 0001193125-23-160060 333-271481 23991014 33 26228460 1 1
2023-06-02 425 425 0001193125-23-159439 000-50484 23986814 34 287801
2023-06-02 8-K 8-K 5.02,9.01 0001193125-23-159435 000-50484 23986806 34 466872 1 1
2023-06-01 DEFA14A DEFA14A 0001193125-23-158466 000-50484 23983068 34 62321
2023-06-01 8-K 8-K 8.01,9.01 0001193125-23-158451 000-50484 23983058 34 203022 1 1
2023-05-31 DEFA14A DEFA14A 0001193125-23-156925 000-50484 23978685 34 56683
2023-05-31 8-K 8-K 8.01,9.01 0001193125-23-156923 000-50484 23978678 34 197368 1 1
2023-05-30 3 xslF345X02/e618678_3-meip.xml 0001193805-23-000806 13999
2023-05-30 3 OWNERSHIP DOCUMENT 0000921895-23-001393 7727
2023-05-30 SC 13D THE SCHEDULE 13D 0000921895-23-001387 005-79594 23977407 34 719917
2023-05-11 8-K 8-K 2.02,9.01 0001193125-23-142119 000-50484 23911822 34 264474 1 1
2023-05-11 10-Q 10-Q 0000950170-23-021179 000-50484 23910766 34 8073567 1 1
2023-05-01 SC 13G j421232sc13g.htm 0001214659-23-006287 005-79594 23873383 34 96223
2023-05-01 UPLOAD filename1.pdf 0000000000-23-004431 40310
2023-04-28 S-4 S-4 0001193125-23-123021 333-271481 23859408 33 6382354
2023-04-14 8-K 8-K 3.03,5.03,8.01,9.01 0001193125-23-102213 000-50484 23821791 34 184284 1 1
2023-03-13 8-K 8-K 7.01 0001193125-23-068392 000-50484 23725562 34 143620 1 1
2023-03-09 SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND V, LLC - MEI PHARMA - SCHEDULE 13D/A(#2E) 0001072613-23-000247 005-79594 23719812 34 111479
2023-03-01 4 FORM 4 SUBMISSION 0001209191-23-014244 5341
2023-02-24 425 425 0001193125-23-047024 000-50484 23661870 34 103091
2023-02-23 425 425 0001193125-23-046823 000-50484 23661180 34 15957663
2023-02-23 8-K 8-K 1.01,5.02,5.03,7.01,9.01 0001193125-23-046815 000-50484 23661135 34 16340127 1 1
2023-02-14 SC 13G SC 13G 0001193125-23-039065 005-79594 23629057 34 129993
2023-02-09 S-8 S-8 0001193125-23-030162 333-269666 23606850 33 150386
2023-02-09 8-K 8-K 2.02,9.01 0001193125-23-030087 000-50484 23606520 34 259434 1 1
2023-02-09 SC 13G/A SC 13G/A 0001193125-23-029989 005-79594 23606166 34 91344
2023-02-09 10-Q 10-Q 0000950170-23-002323 000-50484 23606089 34 7927321 1 1
2023-02-09 SC 13G SCHEDULE 13G 0001104659-23-016458 005-79594 23603765 34 13006
2023-01-06 8-K 8-K 5.07 0001193125-23-003583 000-50484 23515378 34 157485 1 1
2022-12-08 8-K 8-K 5.07,8.01,9.01 0001193125-22-301019 000-50484 221452399 34 244519 1 1
2022-11-14 8-K 8-K 2.02,9.01 0001193125-22-284835 000-50484 221387968 34 239522 1 1
2022-11-14 10-Q 10-Q 0000950170-22-024967 000-50484 221384905 34 7038938 1 1
2022-10-27 DEF 14A DEF 14A 0000950170-22-020312 000-50484 221337261 34 3247512
2022-10-14 PRE 14A PRE 14A 0000950170-22-019570 000-50484 221311350 34 3242209
2022-10-07 8-K 8-K 5.02 0001193125-22-259691 000-50484 221301501 34 143288 1 1
2022-09-15 8-K 8-K 5.02 0001193125-22-245651 000-50484 221246075 34 142544 1 1
2022-09-08 10-K 10-K 0000950170-22-018236 000-50484 221233840 34 11515185 1 1
2022-07-07 4 FORM 4 SUBMISSION 0000899243-22-025740 13952
2022-07-07 8-K 8-K 5.02,9.01 0001193125-22-189565 000-50484 221072343 34 151134 1 1
2022-07-07 4 FORM 4 SUBMISSION 0000899243-22-025712 11367
2022-07-07 4 FORM 4 SUBMISSION 0000899243-22-025711 13945
2022-07-07 4 FORM 4 SUBMISSION 0000899243-22-025710 9143
2022-07-07 4 FORM 4 SUBMISSION 0000899243-22-025709 9297
2022-07-07 4 FORM 4 SUBMISSION 0000899243-22-025708 16137
2022-07-07 4 FORM 4 SUBMISSION 0000899243-22-025702 14886
2022-07-07 4 FORM 4 SUBMISSION 0000899243-22-025700 13891
2022-07-07 4 FORM 4 SUBMISSION 0000899243-22-025699 13911
2022-07-07 4 FORM 4 SUBMISSION 0000899243-22-025698 16180
2022-07-07 4 FORM 4 0001567619-22-013789 6717
2022-07-07 4 FORM 4 0001567619-22-013787 18023
2022-05-31 SC 13G/A SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-22-006621 005-79594 22984229 34 67214
2022-05-23 8-K 8-K 2.02,9.01 0001193125-22-157519 000-50484 22952190 34 266977 1 1
2022-05-23 10-Q 10-Q 0000950170-22-010498 000-50484 22951810 34 10277926 1 1
2022-05-23 10-Q/A 10-Q/A 0000950170-22-010495 000-50484 22951704 34 11992581 1 1
2022-05-23 10-Q/A 10-Q/A 0000950170-22-010489 000-50484 22951620 34 9309911 1 1
2022-05-23 10-K/A 10-K/A 0000950170-22-010487 000-50484 22951518 34 14099331 1 1
2022-05-17 NT 10-Q NT 10-Q 0001193125-22-153056 000-50484 22935015 34 26829
2022-05-13 8-K 8-K 3.01,4.02 0001193125-22-150171 000-50484 22923356 34 158859 1 1
2022-04-07 SC 13G/A meip422.txt 0000814133-22-000091 005-79594 22813657 34 4008
2022-03-25 8-K 8-K 8.01,9.01 0001193125-22-084277 000-50484 22768112 34 203876 1 1
2022-02-14 SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-22-001929 005-79594 22633604 34 66078
2022-02-11 SC 13G meip222.txt 0000814133-22-000072 005-79594 22619070 34 4053
2022-02-10 10-Q 10-Q 0000950170-22-001070 000-50484 22613830 34 7909567 1 1
2022-02-09 SC 13G/A us55279b2025_020922.txt 0000834237-22-008609 005-79594 22608338 34 12325
2022-02-01 SC 13G/A us55279b2025_013122.txt 0000834237-22-003888 005-79594 22575602 34 13181
2021-12-23 8-K 8-K 5.02,9.01 0001193125-21-366182 000-50484 211517199 34 184491 1 1
2021-12-17 8-K 8-K 5.03,5.07,9.01 0001193125-21-361231 000-50484 211502230 34 268574 1 1
2021-12-06 8-K 8-K 8.01,9.01 0001193125-21-349142 000-50484 211473942 34 479574 1 1
2021-12-02 424B5 424B5 0001193125-21-346821 333-238056 211467756 33 711233
2021-11-30 424B5 424B5 0001193125-21-343790 333-238056 211460358 33 714812
2021-11-30 8-K 8-K 8.01,9.01 0001193125-21-342891 000-50484 211458280 34 191064 1 1
2021-11-23 DEFA14A DEFA14A 0001193125-21-338435 000-50484 211438498 34 49661
2021-11-23 4 FORM 4 0001567619-21-021035 5392
2021-11-23 3 FORM 3 0001567619-21-021033 8338
2021-11-23 8-K 8-K 5.02,9.01 0001193125-21-337594 000-50484 211434756 34 169797 1 1
2021-11-10 10-Q 10-Q 0000950170-21-004063 000-50484 211396418 34 6955119 1 1
2021-10-28 DEFA14A DEFA14A 0001193125-21-311274 000-50484 211358196 34 377540
2021-10-28 DEF 14A DEF 14A 0001193125-21-311264 000-50484 211358164 34 923134
2021-10-06 PRE 14A PRE 14A 0001193125-21-293221 000-50484 211310030 34 1157419
2021-09-02 10-K 10-K 0000950170-21-001655 000-50484 211233218 34 11632337 1 1
2021-08-05 8-K 8-K 5.02,9.01 0001193125-21-237802 000-50484 211148964 34 78314
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045666 12695
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045663 12675
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045660 7927
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045658 12729
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045655 10152
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045653 8081
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045651 13949
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045648 12736
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045645 15148
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045643 13878
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045640 16833
2021-07-06 4 FORM 4 SUBMISSION 0001209191-21-045638 17000
2021-06-14 8-K 8-K 8.01,9.01 0001193125-21-189193 000-50484 211012851 34 9082079
2021-05-27 4 FORM 4 SUBMISSION 0001209191-21-036188 7237
2021-05-06 S-8 S-8 0001193125-21-153301 333-255830 21898008 33 147642
2021-05-06 10-Q 10-Q 0001193125-21-153237 000-50484 21897576 34 4353012 1
2021-05-05 4 FORM 4 0001567619-21-009092 13432
2021-05-05 3 FORM 3 0001567619-21-009090 16273
2021-04-30 8-K 8-K 5.02,8.01,9.01 0001193125-21-144939 000-50484 21877674 34 34816
2021-04-13 8-K 8-K 2.02,8.01,9.01 0001193125-21-114670 000-50484 21823121 34 8302166
2021-02-24 4 FORM 4 SUBMISSION 0001209191-21-013670 4448
2021-02-16 SC 13G/A AMENDMENT NO. 4 TO SCHEDULE 13G 0001193125-21-044754 005-79594 21637417 34 66243
2021-02-16 SC 13G/A SC 13G/A 0001193125-21-043563 005-79594 21632844 34 115914
2021-02-12 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0001213900-21-009009 005-79594 21628135 34 51829
2021-02-11 SC 13G/A AMENDMENT NO. 3 TO THE SCHEDULE 13G 0000921895-21-000341 005-79594 21621146 34 282973
2021-02-04 10-Q 10-Q 0001193125-21-028775 000-50484 21591050 34 4012435 1
2021-02-02 SC 13G us55279b2025_020221.txt 0000834237-21-007060 005-79594 21580833 34 13143
2021-01-08 S-8 S-8 0001193125-21-005249 333-251976 21517877 33 55333
2020-12-17 8-K 8-K 5.02,5.07,9.01 0001193125-20-320152 000-50484 201396863 34 132070
2020-11-10 8-K 8-K 8.01,9.01 0001193125-20-290299 000-50484 201302100 34 214648
2020-11-10 424B5 424B5 0001193125-20-290246 333-238056 201301827 33 215650
2020-11-10 10-Q 10-Q 0001193125-20-290130 000-50484 201301046 34 3933131 1
2020-10-27 DEF 14A DEF 14A 0001193125-20-278378 000-50484 201264151 34 1361890
2020-09-09 10-K FORM 10-K 0001193125-20-242169 000-50484 201166567 34 7060382 1
2020-07-27 4 FORM 4 SUBMISSION 0001209191-20-043719 7145
2020-07-07 4 FORM 4 SUBMISSION 0000899243-20-018618 11479
2020-07-07 4 FORM 4 SUBMISSION 0000899243-20-018617 11513
2020-07-07 4 FORM 4 SUBMISSION 0000899243-20-018616 11459
2020-07-07 4 FORM 4 SUBMISSION 0000899243-20-018615 9155
2020-07-07 4 FORM 4 SUBMISSION 0000899243-20-018614 15716
2020-07-07 4 FORM 4 SUBMISSION 0000899243-20-018613 13950
2020-07-07 4 FORM 4 SUBMISSION 0000899243-20-018612 6622
2020-07-07 4 FORM 4 SUBMISSION 0000899243-20-018611 12578
2020-07-07 4 FORM 4 SUBMISSION 0000899243-20-018610 12733
2020-07-07 4 FORM 4 SUBMISSION 0000899243-20-018606 11521
2020-07-07 4 FORM 4 SUBMISSION 0000899243-20-018601 15676
2020-07-07 4 FORM 4 SUBMISSION 0000899243-20-018597 6781
2020-07-02 8-K 8-K 8.01,9.01 0001193125-20-185881 000-50484 201007189 34 40927
2020-06-12 424B5 424B5 0001193125-20-167242 333-238056 20959052 33 204764
2020-05-18 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-05-18 16:00:00 9999999995-20-001189 333-238056 20891509 33 1806
2020-05-14 CORRESP filename1.htm 0001193125-20-142862 6916
2020-05-14 UPLOAD filename1.pdf 0000000000-20-004278 40332
2020-05-07 S-3 S-3 0001193125-20-135593 333-238056 20854564 33 215466
2020-05-07 10-Q 10-Q 0001193125-20-135561 000-50484 20854509 34 3561786 1
2020-04-14 4 FORM 4 SUBMISSION 0000899243-20-010723 5467
2020-04-14 3 FORM 3 SUBMISSION 0000899243-20-010721 7170
2020-04-14 8-K 8-K 5.02,8.01,9.01 0001193125-20-106585 000-50484 20790841 34 39042
2020-04-14 8-K 8-K 1.01,1.02,8.01,9.01 0001193125-20-105808 000-50484 20790062 34 81535
2020-03-20 8-K 8-K 5.03,9.01 0001193125-20-080639 000-50484 20732025 34 101243
2020-02-14 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0001193125-20-038284 005-79594 20620210 34 65978
2020-02-14 SC 13G/A AMENDMENT NO. 2 TO THE SCHEDULE 13G 0000921895-20-000520 005-79594 20618148 34 294523
2020-02-13 SC 13G/A SCHEDULE 13G/A 0001123292-20-000249 005-79594 20611843 34 88256
2020-02-13 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-20-003605 005-79594 20611118 34 50531
2020-02-06 10-Q 10-Q 0001193125-20-026751 000-50484 20582623 34 3489041 1
2020-02-05 SC 13G SC 13G 0001193125-20-025221 005-79594 20578194 34 101782
2019-12-30 SC 13D/A GROWTH EQUITY OPPORTUNITIES FUND V, LLC - MEI PHARMA, INC. -- SCHEDULE 13D/A (AM 0001072613-19-000317 005-79594 191316596 34 605262
2019-12-20 4 FORM 4 SUBMISSION 0001209191-19-061475 4551
2019-12-20 4 FORM 4 SUBMISSION 0001209191-19-061473 4460
2019-12-20 4 FORM 4 SUBMISSION 0001209191-19-061471 4594
2019-12-20 4 FORM 4 SUBMISSION 0001209191-19-061469 4623
2019-12-18 8-K 8-K 8.01,9.01 0001193125-19-316554 000-50484 191291171 34 265451
2019-12-18 424B5 424B5 0001193125-19-316543 333-217645 191291167 33 535152
2019-12-16 424B5 424B5 0001193125-19-315266 333-217645 191287757 33 537725
2019-12-06 8-K 8-K 5.07 0001193125-19-308280 000-50484 191273351 34 25140
2019-12-06 10-K/A 10-K/A 0001193125-19-308275 000-50484 191273311 34 92478
2019-11-07 10-Q 10-Q 0001193125-19-287262 000-50484 191200205 34 3232582 1
2019-10-23 DEF 14A DEF 14A 0001193125-19-271911 000-50484 191162568 34 613937
2019-10-01 4 FORM 4 SUBMISSION 0001209191-19-051197 6947
2019-09-25 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001193125-19-254809 005-79594 191114861 34 64463
2019-09-09 4 FORM 4 SUBMISSION 0001209191-19-048913 5140
2019-08-28 10-K 10-K 0001193125-19-232454 000-50484 191062161 34 6075994 1
2019-07-03 4 FORM 4 SUBMISSION 0001209191-19-040989 5524
2019-07-03 4 FORM 4 SUBMISSION 0001209191-19-040987 5523
2019-07-03 4 FORM 4 SUBMISSION 0001209191-19-040985 5483
2019-07-03 4 FORM 4 SUBMISSION 0001209191-19-040984 5455
2019-07-03 4 FORM 4 SUBMISSION 0001209191-19-040983 5326
2019-07-03 4 FORM 4 SUBMISSION 0001209191-19-040981 5324
2019-07-03 4 FORM 4 SUBMISSION 0001209191-19-040980 5306
2019-07-03 4 FORM 4 SUBMISSION 0001209191-19-040979 5360
2019-07-03 4 FORM 4 SUBMISSION 0001209191-19-040977 5215
2019-07-03 4 FORM 4 SUBMISSION 0001209191-19-040976 5364
2019-07-03 4 FORM 4 SUBMISSION 0001209191-19-040975 5367
2019-07-03 4 FORM 4 SUBMISSION 0001209191-19-040974 5296
2019-07-03 3 FORM 3 SUBMISSION 0001209191-19-040973 6927
2019-07-03 8-K 8-K 5.02,8.01,9.01 0001193125-19-189160 000-50484 19941607 34 36446
2019-06-03 8-K 8-K 8.01,9.01 0001193125-19-164088 000-50484 19873315 34 67881
2019-05-09 10-Q 10-Q 0001193125-19-142945 000-50484 19810389 34 4504910 1
2019-02-22 CT ORDER filename1.pdf 20190222,20190222 9999999997-19-000562 000-50484 19625815 34 106207
2019-02-14 SC 13G/A d8189593_13g-a.htm 0000919574-19-001802 005-79594 19607805 34 137411

Latest XBRL company facts

One latest value per concept from companyfacts (341 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 29.88M 2026-10-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
dei EntityPublicFloat Entity Public Float USD 43.00M 2025-12-31 2026 FY 10-K 2026-09-28 0001193125-26-405328
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 645,430 2024-07-01 2024-07-31 2026 FY 10-K 2026-09-28 0001193125-26-405328
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 708,134 2024-07-01 2024-07-31 2026 FY 10-K 2026-09-28 0001193125-26-405328
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 18 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
ffd NetFeeAmt NetFeeAmt USD 333.93 2026-09-28 S-3 2026-09-28 0001193125-26-405423
ffd TtlFeeAmt TtlFeeAmt USD 333.93 2026-09-28 S-3 2026-09-28 0001193125-26-405423
ffd TtlOfferingAmt TtlOfferingAmt USD 2.42M 2026-09-28 S-3 2026-09-28 0001193125-26-405423
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-28 S-3 2026-09-28 0001193125-26-405423
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-09-28 S-3 2026-09-28 0001193125-26-405423
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 280,000 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 0 2025-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.43M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 192,000 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 1.76M 2024-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 215.93M 2015-06-30 2015 FY 10-K 2015-09-02 0001193125-15-309992
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 523.30M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings Adjustments to Additional Paid in Capital, Dividends in Excess of Retained Earnings USD 11.66M 2023-07-01 2024-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 119,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 3.65M 2021-07-01 2022-06-30 2023 FY 10-K 2023-09-26 0000950170-23-049927
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 500,000 2022-07-01 2023-06-30 2024 FY 10-K 2024-09-19 0000950170-24-108185
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2020-07-01 2021-06-30 2021 FY 10-K/A 2022-05-23 0000950170-22-010487
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 4.88M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap AreaOfLand Area of Land sqft 32,800 2020-07-31 2025 Q1 10-Q 2025-11-14 0001193125-25-283111
us-gaap Assets Assets USD 58.40M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap AssetsCurrent Assets, Current USD 6.20M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2024-07-01 2024-09-30 2025 Q1 10-Q 2024-11-12 0000950170-24-125328
us-gaap CapitalLeasesFutureMinimumPaymentsDueCurrent Capital Leases, Future Minimum Payments Due, Next Twelve Months USD 188,000 2013-06-30 2013 FY 10-K 2013-09-18 0001193125-13-369722
us-gaap CapitalLeasesFutureMinimumPaymentsDueInTwoYears Capital Leases, Future Minimum Payments Due in Two Years USD 213,000 2013-06-30 2013 FY 10-K 2013-09-18 0001193125-13-369722
us-gaap CapitalUnitsAuthorized Capital Units, Authorized shares 226.10M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 4.28M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -3.72M 2018-07-01 2019-06-30 2019 FY 10-K 2019-08-28 0001193125-19-232454
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 5.70M 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 12.55M 2021-12-31 2022 Q2 10-Q/A 2022-05-23 0000950170-22-010495
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 4.28M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -1.43M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights Class of Warrant or Right, Exercise Price of Warrants or Rights (Deprecated 2014-01-31) USD/Right 130.2 2013-06-30 2013 FY 10-K 2013-09-18 0001193125-13-369722
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 6 2016-09-30 2017 Q1 10-Q 2016-11-09 0001193125-16-763751
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 16.06M 2019-03-31 2019 Q3 10-Q 2019-05-09 0001193125-19-142945
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 5.84M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CommonStockDividendsPerShareDeclared Common Stock, Dividends, Per Share, Declared USD/shares 1.75 2023-07-01 2024-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 226.00M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 36.78M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 30.19M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable USD 5.27M 2019-06-30 2020 FY 10-K 2020-09-09 0001193125-20-242169
us-gaap CommonStockValue Common Stock, Value, Issued USD 0 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -11.19M 2012-07-01 2013-06-30 2013 FY 10-K 2013-09-18 0001193125-13-369722
us-gaap ContractualObligation Contractual Obligation USD 700,000 2019-06-30 2019 FY 10-K 2019-08-28 0001193125-19-232454
us-gaap ContractWithCustomerAssetNetCurrent Contract with Customer, Asset, after Allowance for Credit Loss, Current USD 85,000 2023-06-30 2023 FY 10-K 2023-09-26 0000950170-23-049927
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 0 2024-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized Contract with Customer, Liability, Change in Timeframe, Performance Obligation Satisfied, Revenue Recognized USD 0 2023-07-01 2024-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueModificationOfContract Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Modification of Contract USD 0 2023-07-01 2024-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD -317,000 2023-07-01 2023-09-30 2024 Q1 10-Q 2023-11-09 0000950170-23-061976
us-gaap ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod Contract with Customer, Performance Obligation Satisfied in Previous Period USD 19.00M 2020-07-01 2020-09-30 2021 Q1 10-Q 2020-11-10 0001193125-20-290130
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 0 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-08 0000950170-22-018236
us-gaap CostOfServices Cost of Services (Deprecated 2018-01-31) USD 3.38M 2017-07-01 2018-06-30 2018 FY 10-K 2018-08-30 0001193125-18-263586
us-gaap CostsAndExpenses Costs and Expenses USD -14.52M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 1.10M 2023-10-31 2024 FY 10-K 2024-09-19 0000950170-24-108185
us-gaap CryptoAssetCost CryptoAssetCost USD 65.65M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CryptoAssetDisposition CryptoAssetDisposition USD 1.00M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CryptoAssetFairValue CryptoAssetFairValue USD 46.18M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CryptoAssetFairValueCurrent CryptoAssetFairValueCurrent USD 46.18M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CryptoAssetFairValueNoncurrent CryptoAssetFairValueNoncurrent USD 46.18M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CryptoAssetNumberOfUnits CryptoAssetNumberOfUnits Crypto 687,098 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CryptoAssetPurchase CryptoAssetPurchase USD 7.91M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CryptoAssetRealizedAndUnrealizedGainLossOperating CryptoAssetRealizedAndUnrealizedGainLossOperating USD 16.90M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CryptoAssetRealizedLossOperating CryptoAssetRealizedLossOperating USD 1.44M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap CryptoAssetUnrealizedLossOperating CryptoAssetUnrealizedLossOperating USD 54.41M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2024-06-30 2024 FY 10-K 2024-09-19 0000950170-24-108185
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 0 2024-06-30 2024 FY 10-K 2024-09-19 0000950170-24-108185
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 64.90M 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-26 0000950170-23-049927
us-gaap DeferredTaxAssetsCapitalLossCarryforwards Deferred Tax Assets, Capital Loss Carryforwards USD 26.38M 2016-06-30 2017 FY 10-K 2017-09-05 0001193125-17-276135
us-gaap DeferredTaxAssetsCharitableContributionCarryforwards Deferred Tax Assets, Charitable Contribution Carryforwards USD 8,000 2023-06-30 2023 FY 10-K 2023-09-26 0000950170-23-049927
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2024-06-30 2024 FY 10-K 2024-09-19 0000950170-24-108185
us-gaap DeferredTaxAssetsDerivativeInstruments Deferred Tax Assets, Derivative Instruments USD 183,000 2011-06-30 2012 FY 10-K 2012-09-18 0001193125-12-394598
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 91.43M 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 6.74M 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap DeferredTaxAssetsInvestmentInSubsidiaries Deferred Tax Assets, Investment in Subsidiaries USD 26.42M 2011-06-30 2012 FY 10-K 2012-09-18 0001193125-12-394598
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 63.83M 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 286.70M 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 51.80M 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 1.29M 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation USD 1.25M 2023-06-30 2023 FY 10-K 2023-09-26 0000950170-23-049927
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 636,000 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 48,000 2023-06-30 2023 FY 10-K 2023-09-26 0000950170-23-049927
us-gaap DeferredTaxAssetsUnrealizedCurrencyLosses Deferred Tax Assets, Unrealized Currency Losses USD 193,000 2011-06-30 2012 FY 10-K 2012-09-18 0001193125-12-394598
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 91.43M 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 804,000 2014-06-30 2015 FY 10-K 2015-09-02 0001193125-15-309992
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 28,000 2011-06-30 2012 FY 10-K 2012-09-18 0001193125-12-394598
us-gaap DeferredTaxLiabilitiesUnrealizedCurrencyTransactionGains Deferred Tax Liabilities, Unrealized Currency Transaction Gains USD 13,000 2011-06-30 2012 FY 10-K 2012-09-18 0001193125-12-394598
us-gaap Depreciation Depreciation USD 100,000 2023-07-01 2024-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -1.17M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap DerivativeGainOnDerivative Derivative, Gain on Derivative USD 1.14M 2011-07-01 2012-06-30 2014 FY 10-K 2014-09-09 0001193125-14-336166
us-gaap DerivativeLiabilities Derivative Liability USD 1.10M 2011-06-30 2014 FY 10-K 2014-09-09 0001193125-14-336166
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 528,000 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap DerivativeNotionalAmount Derivative, Notional Amount USD 0 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap DividendsCash Dividends, Cash USD 11.66M 2023-10-01 2023-12-31 2024 Q3 10-Q 2024-05-09 0000950170-24-056834
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0.48 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.04 2019-07-01 2019-09-30 2020 Q1 10-Q 2019-11-07 0001193125-19-287262
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0.48 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.18 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure 0.8 2019-07-01 2020-06-30 2020 FY 10-K 2020-09-09 0001193125-20-242169
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2013-07-01 2014-06-30 2014 FY 10-K 2014-09-09 0001193125-14-336166
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure 0.02 2010-07-01 2011-06-30 2012 FY 10-K 2012-09-18 0001193125-12-394598
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.03 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 651,000 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 3.44M 2013-03-31 2013 Q3 10-Q 2013-05-09 0001193125-13-208929
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 400,000 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.6 2012-09-30 2013 Q1 10-Q 2012-11-13 0001193125-12-465326
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD -37.79M 2018-07-01 2019-06-30 2019 FY 10-K 2019-08-28 0001193125-19-232454
us-gaap FairValueAssumptionsExercisePrice Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) USD 2.81 2018-06-30 2018 FY 10-K 2018-08-30 0001193125-18-263586
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2017-07-01 2018-06-30 2018 FY 10-K 2018-08-30 0001193125-18-263586
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.773 2017-07-01 2018-06-30 2018 FY 10-K 2018-08-30 0001193125-18-263586
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.027 2017-07-01 2018-06-30 2018 FY 10-K 2018-08-30 0001193125-18-263586
us-gaap FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) USD 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-19 0000950170-24-108185
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 0 2022-07-01 2023-06-30 2024 FY 10-K 2024-09-19 0000950170-24-108185
us-gaap FinancialServicesCosts Financial Services Costs (Deprecated 2018-01-31) USD 406,000 2011-07-01 2012-06-30 2014 FY 10-K 2014-09-09 0001193125-14-336166
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 261,000 2019-06-30 2020 FY 10-K 2020-09-09 0001193125-20-242169
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD -508,000 2000-12-01 2014-03-31 2014 Q3 10-Q 2014-05-08 0001193125-14-188897
us-gaap GainLossOnInvestments Gain (Loss) on Investments USD 100,000 2011-07-01 2012-06-30 2014 FY 10-K 2014-09-09 0001193125-14-336166
us-gaap GainLossOnSaleOfOtherAssets Gain (Loss) on Disposition of Other Assets USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 2.35M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-08 0000950170-22-018236
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 10.40M 2024-06-18 2025 Q1 10-Q 2025-11-14 0001193125-25-283111
us-gaap ImpairmentOfLongLivedAssetsToBeDisposedOf Impairment of Long-Lived Assets to be Disposed of USD 0 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -71.15M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -71.15M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -54.45M 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-08 0000950170-22-018236
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 13.30M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2019-07-01 2020-06-30 2020 FY 10-K 2020-09-09 0001193125-20-242169
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -41,000 2011-07-01 2012-06-30 2014 FY 10-K 2014-09-09 0001193125-14-336166
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -14.94M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 1,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 108,000 2010-07-01 2011-06-30 2012 FY 10-K 2012-09-18 0001193125-12-394598
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1.45M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -1,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 19,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2022-07-01 2022-09-30 2022 Q1 10-Q 2022-11-14 0000950170-22-024967
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 106,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap IncreaseDecreaseInCommodityContractAssetsAndLiabilities Increase (Decrease) in Commodity Contract Assets and Liabilities USD 4.72M 2020-07-01 2021-06-30 2021 FY 10-K 2021-09-02 0000950170-21-001655
us-gaap IncreaseDecreaseInContractWithCustomerAsset Increase (Decrease) in Contract with Customer, Asset USD 2.57M 2021-07-01 2021-12-31 2022 Q2 10-Q/A 2022-05-23 0000950170-22-010495
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -48,000 2018-07-01 2018-09-30 2019 Q1 10-Q 2018-11-08 0001193125-18-322588
us-gaap IncreaseDecreaseInDueToRelatedPartiesCurrent Increase (Decrease) in Due to Related Parties, Current USD -301,000 2010-07-01 2011-06-30 2012 FY 10-K 2012-09-18 0001193125-12-394598
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 0 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -27,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 515,000 2025-07-01 2025-09-30 2025 Q1 10-Q 2025-11-14 0001193125-25-283111
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 622,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap IncreaseDecreaseInReceivables Increase (Decrease) in Receivables USD -2.21M 2020-07-01 2020-12-31 2021 Q2 10-Q 2021-02-04 0001193125-21-028775
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-26 0000950170-23-049927
us-gaap InterestAndDividendIncomeOperating Interest and Dividend Income, Operating USD 267,000 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap InterestExpenseOther Interest Expense, Other USD 0 2021-07-01 2021-12-31 2022 Q2 10-Q/A 2022-05-23 0000950170-22-010495
us-gaap InvestmentIncomeInterestAndDividend Investment Income, Interest and Dividend USD 36,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 16.21M 2025-07-01 2025-09-30 2025 Q1 10-Q 2025-11-14 0001193125-25-283111
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 405,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 67,000 2018-07-01 2019-06-30 2019 FY 10-K 2019-08-28 0001193125-19-232454
us-gaap LeaseCost Lease, Cost USD 0 2025-01-01 2025-03-31 2025 Q3 10-Q 2025-05-13 0000950170-25-070276
us-gaap LegalFees Legal Fees USD 296,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 14.63M 2024-03-31 2024 Q3 10-Q 2024-05-09 0000950170-24-056834
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 4.38M 2023-06-30 2023 FY 10-K 2023-09-26 0000950170-23-049927
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.91M 2024-03-31 2024 Q3 10-Q 2024-05-09 0000950170-24-056834
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 2.71M 2023-06-30 2023 FY 10-K 2023-09-26 0000950170-23-049927
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2.71M 2024-03-31 2024 Q3 10-Q 2024-05-09 0000950170-24-056834
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.55M 2024-03-31 2024 Q3 10-Q 2024-05-09 0000950170-24-056834
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.48M 2024-03-31 2024 Q3 10-Q 2024-05-09 0000950170-24-056834
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 584,000 2024-03-31 2024 Q3 10-Q 2024-05-09 0000950170-24-056834
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 2.96M 2024-03-31 2024 Q3 10-Q 2024-05-09 0000950170-24-056834
us-gaap Liabilities Liabilities USD 1.71M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 58.40M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap LiabilitiesCurrent Liabilities, Current USD 1.71M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap LicenseCosts License Costs (Deprecated 2018-01-31) USD 21.50M 2000-12-01 2014-03-31 2014 Q3 10-Q 2014-05-08 0001193125-14-188897
us-gaap LicensesRevenue Licenses Revenue (Deprecated 2018-01-31) USD 20.88M 2016-07-01 2017-06-30 2018 FY 10-K 2018-08-30 0001193125-18-263586
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -2.40M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 189,000 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-09 0001193125-18-156845
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 3.15M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 15.10M 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-09 0001193125-18-156845
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -2.18M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -17.55M 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-09 0001193125-18-156845
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 16.02M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -31.84M 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-26 0000950170-23-049927
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -31.84M 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-26 0000950170-23-049927
us-gaap NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1 Noncash or Part Noncash Acquisition, Noncash Financial or Equity Instrument Consideration, Shares Issued shares 500,000 2012-07-01 2013-06-30 2015 FY 10-K 2015-09-02 0001193125-15-309992
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1.50M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 2 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 2 2013-07-01 2014-06-30 2014 FY 10-K 2014-09-09 0001193125-14-336166
us-gaap OperatingExpenses Operating Expenses USD 21.00M 2015-07-01 2016-06-30 2016 FY 10-K 2016-09-06 0001193125-16-701415
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 14.52M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap OperatingLeaseCost Operating Lease, Cost USD 0 2025-07-01 2025-09-30 2025 Q1 10-Q 2025-11-14 0001193125-25-283111
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 600 2022-07-01 2022-09-30 2022 Q1 10-Q 2022-11-14 0000950170-22-024967
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 0 2024-06-18 2025 Q1 10-Q 2025-11-14 0001193125-25-283111
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 0 2024-06-30 2024 FY 10-K 2024-09-19 0000950170-24-108185
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2024-06-30 2024 FY 10-K 2024-09-19 0000950170-24-108185
us-gaap OperatingLeasePayments Operating Lease, Payments USD 0 2025-07-01 2025-09-30 2025 Q1 10-Q 2025-11-14 0001193125-25-283111
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2025-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 22,000 2023-07-01 2024-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 0 2024-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 343,000 2016-06-30 2016 FY 10-K 2016-09-06 0001193125-16-701415
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 86,000 2017-03-31 2017 Q3 10-Q 2017-05-04 0001193125-17-157424
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 118,000 2011-07-01 2012-06-30 2012 FY 10-K 2012-09-18 0001193125-12-394598
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.075 2024-03-31 2024 Q3 10-Q 2024-05-09 0000950170-24-056834
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 46,000 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 625,000 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -31,000 2003-07-01 2004-06-30 2013 FY 10-K 2013-09-18 0001193125-13-369722
us-gaap OtherExpenses Other Expenses USD 497,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 5,000 2020-07-01 2020-09-30 2021 Q1 10-Q 2020-11-10 0001193125-20-290130
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 36,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap OtherOperatingIncomeExpenseNet Other Operating Income (Expense), Net USD -58.13M 2025-07-01 2026-03-31 2026 Q3 10-Q 2026-05-13 0001193125-26-220687
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 117,000 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap OtherReceivables Other Receivables USD 85,000 2023-06-30 2023 FY 10-K 2023-09-26 0000950170-23-049927
us-gaap PaymentForAcquisitionCryptoAsset PaymentForAcquisitionCryptoAsset USD 7.91M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap PaymentsForProceedsFromProductiveAssets Payments for (Proceeds from) Productive Assets USD 7,000 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-19 0000950170-24-108185
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 2.40M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap PaymentsForRepurchaseOfWarrants Payments for Repurchase of Warrants USD 365,000 2011-09-28 2014 FY 10-K 2014-09-09 0001193125-14-336166
us-gaap PaymentsOfDividends Payments of Dividends USD 11.70M 2023-12-06 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 0 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-26 0000950170-23-049927
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-19 0000950170-24-108185
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 0 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap PreferredStockConvertibleConversionRatio PreferredStockConvertibleConversionRatio Rate 0.052 2023-02-28 2023 Q3 10-Q 2023-05-11 0000950170-23-021179
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 100,000 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 100,000 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.92M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap PrepaidInsurance Prepaid Insurance USD 799,000 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap ProceedsFromDisposalCryptoAsset ProceedsFromDisposalCryptoAsset USD 1.00M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 665,000 2000-12-01 2014-03-31 2014 Q3 10-Q 2014-05-08 0001193125-14-188897
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 3.14M 2020-07-01 2021-06-30 2021 FY 10-K/A 2022-05-23 0000950170-22-010487
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 665,000 2011-03-01 2011-03-31 2013 FY 10-K 2013-09-18 0001193125-13-369722
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments Proceeds from Maturities, Prepayments and Calls of Short-term Investments USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap ProceedsFromSaleOfFurnitureAndFixtures Proceeds from Sale of Furniture and Fixtures USD 1 2024-06-18 2025 Q1 10-Q 2025-11-14 0001193125-25-283111
us-gaap ProceedsFromSaleOfOtherAssetsInvestingActivities Proceeds from Sale of Other Assets, Investing Activities USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-26 0000950170-23-049927
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 1.12M 2018-07-01 2019-06-30 2021 FY 10-K/A 2022-05-23 0000950170-22-010487
us-gaap ProfessionalFees Professional Fees USD 651,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD 16.02M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 2.16M 2024-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 0 2025-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 22,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminated Restructuring and Related Cost, Number of Positions Eliminated Employee 11 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-19 0000950170-24-108185
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.51 2023-07-01 2024-03-31 2024 Q3 10-Q 2024-05-09 0000950170-24-056834
us-gaap RestructuringCosts Restructuring Costs USD 2.60M 2022-07-01 2023-06-30 2023 FY 10-K 2023-09-26 0000950170-23-049927
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -459.29M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 488,000 2018-07-01 2018-09-30 2019 Q1 10-Q 2018-11-08 0001193125-18-322588
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 89.90M 2021-03-31 2021 Q3 10-Q 2021-05-06 0001193125-21-153237
us-gaap Revenues Revenues USD 0 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-19 0000950170-24-108185
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 75 2003-12-31 2013 FY 10-K 2013-09-18 0001193125-13-369722
us-gaap SalesRevenueServicesNet Sales Revenue, Services, Net (Deprecated 2018-01-31) USD 1.62M 2017-07-01 2018-06-30 2018 FY 10-K 2018-08-30 0001193125-18-263586
us-gaap SecurityDeposit Security Deposit USD 0 2025-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap SeveranceCosts1 Severance Costs USD 6.70M 2024-08-01 2024-08-31 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 119,000 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 8.63 2013-03-01 2013-03-29 2013 Q3 10-Q 2013-05-09 0001193125-13-208929
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.914 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 1.58 2013-07-01 2014-03-31 2014 Q3 10-Q 2014-05-08 0001193125-14-188897
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.56 2013-07-01 2014-03-31 2014 Q3 10-Q 2014-05-08 0001193125-14-188897
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.037 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.017 2013-07-01 2014-03-31 2014 Q3 10-Q 2014-05-08 0001193125-14-188897
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.001 2013-07-01 2014-03-31 2014 Q3 10-Q 2014-05-08 0001193125-14-188897
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2023-09-30 2024 Q1 10-Q 2023-11-09 0000950170-23-061976
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 819,813 2023-09-30 2024 Q1 10-Q 2023-11-09 0000950170-23-061976
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 49.16 2023-09-30 2024 Q1 10-Q 2023-11-09 0000950170-23-061976
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 0 2020-07-01 2020-09-30 2021 Q1 10-Q 2020-11-10 0001193125-20-290130
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 8,833 2013-07-01 2014-06-30 2014 FY 10-K 2014-09-09 0001193125-14-336166
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 10.33 2013-07-01 2014-06-30 2014 FY 10-K 2014-09-09 0001193125-14-336166
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 293,313 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.16M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.43 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 184,400 2022-06-30 2022 FY 10-K 2022-09-08 0000950170-22-018236
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 86,250 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-08 0000950170-22-018236
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 3.49 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-08 0000950170-22-018236
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 3.49 2022-06-30 2022 FY 10-K 2022-09-08 0000950170-22-018236
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.73M 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 12.8 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 0 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 1.73M 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 12.8 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 5.40M 2019-07-01 2020-06-30 2020 FY 10-K 2020-09-09 0001193125-20-242169
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 130,000 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-08 0000950170-22-018236
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 3.49 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-08 0000950170-22-018236
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased USD/shares 1.47 2025-12-31 2025 Q2 10-Q 2026-02-17 0001193125-26-053215
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 1.64 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-08 0000950170-22-018236
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0 2020-07-01 2020-09-30 2021 Q1 10-Q 2020-11-10 0001193125-20-290130
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 30.14 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 2.08 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price USD/shares 10.83 2013-06-30 2013 FY 10-K 2013-09-18 0001193125-13-369722
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable shares 145,596 2013-06-30 2013 FY 10-K 2013-09-18 0001193125-13-369722
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding shares 635,094 2013-06-30 2013 FY 10-K 2013-09-18 0001193125-13-369722
us-gaap SharePrice Share Price USD/shares 5.34 2012-05-11 2013 Q2 10-Q 2013-02-12 0001193125-13-050392
us-gaap ShortTermInvestments Short-term Investments USD 0 2025-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 56.70M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.167 2012-12-18 2015 FY 10-K 2015-09-02 0001193125-15-309992
us-gaap StockIssued1 Stock Issued USD 500,000 2000-12-01 2012-12-31 2013 Q2 10-Q 2013-02-12 0001193125-13-050392
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 0 2015-07-01 2016-03-31 2016 Q3 10-Q 2016-05-05 0001193125-16-578754
us-gaap StockIssuedDuringPeriodSharesPurchaseOfAssets Stock Issued During Period, Shares, Purchase of Assets shares 195,756 2012-08-22 2017 FY 10-K 2017-09-05 0001193125-17-276135
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 348.55M 2021-07-01 2022-06-30 2022 FY 10-K 2022-09-08 0000950170-22-018236
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 48.67M 2021-07-01 2022-06-30 2023 FY 10-K 2023-09-26 0000950170-23-049927
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 500,000 2012-08-08 2012-08-31 2018 Q1 10-Q 2017-11-08 0001193125-17-336509
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD -40,000 2022-07-01 2023-06-30 2024 FY 10-K 2024-09-19 0000950170-24-108185
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 443,000 2006-07-01 2007-06-30 2013 FY 10-K 2013-09-18 0001193125-13-369722
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 572,000 2021-07-01 2022-06-30 2023 FY 10-K 2023-09-26 0000950170-23-049927
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 2.42M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 6.59M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap TreasuryStockCommonValue Treasury Stock, Common, Value USD 7.32M 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap TreasuryStockSharesAcquired Treasury Stock, Shares, Acquired shares 2.21M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap TreasuryStockValueAcquiredCostMethod Treasury Stock, Value, Acquired, Cost Method USD 2.42M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap UnbilledContractsReceivable Unbilled Contracts Receivable USD 10.00M 2022-06-30 2022 FY 10-K 2022-09-08 0000950170-22-018236
us-gaap UnbilledReceivablesCurrent Unbilled Receivables, Current USD 0 2024-06-30 2024 FY 10-K 2024-09-19 0000950170-24-108185
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 0 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 17.70M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001193125-26-405328
us-gaap WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure USD 0 2022-12-31 2024 FY 10-K 2024-09-19 0000950170-24-108185
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 33.18M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 73.63M 2019-07-01 2019-09-30 2020 Q1 10-Q 2019-11-07 0001193125-19-287262
us-gaap WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation shares 0 2024-07-01 2025-06-30 2025 FY 10-K 2025-09-26 0001193125-25-220421
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 91.08M 2019-07-01 2020-06-30 2020 FY 10-K 2020-09-09 0001193125-20-242169
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 33.17M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-05 0001193125-26-449764
us-gaap WeightedAverageNumberOfSharesRestrictedStock Weighted Average Number of Shares, Restricted Stock shares 367,000 2017-07-01 2018-06-30 2020 FY 10-K 2020-09-09 0001193125-20-242169

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →